In the first of a three-part series, pharma brand directors discuss how their role has evolved amid the biggest marketing trends in 2026.

Aurinia Pharmaceuticals announced Michael Hearne joined as CFO and Thomas Wei as chief scientific officer. Kyle C. Bechter ...

Kickback penalties pale in comparison to drugmaker revenue; Merck makes a $6.7 billion deal in leukemia space; Bipartisan ...

AbbVie is building out its Striking Out Cancer initiative, which launched last year in partnership with the Chicago Cubs ...

Most people who get their health coverage through the Affordable Care Act say they face sharply higher costs, with many ...

A new enforcement action from FDA signals that executive podcast appearances can be regulated like traditional ads when ...

The demand-side platform (DSP) pushes back on Omnicom’s audit as routine oversight, even as its shares tumble around 7% in ...

Multiple brands have reported less than ideal results from their first few weeks of experimenting with ChatGPT Ads, citing ...

Backed by access to more than 1,400 patient communities through Syneos Health, the offering is designed to help brands ...

Across the health industry, leaders are placing bets on what will endure in a time of compounding uncertainty.

Peptides find potential ally in RFK Jr.; Promising Lyme vaccine could face approval hurdle; Iran war may pose risk to generic ...

State and local governments nationwide are receiving billions in opioid settlement cash over nearly two decades and are meant ...